AOCI at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s AOCI?
- Pacira BioSciences, Inc. (PCRX) reported AOCI of $3.46M in Q1 2026.
- How has Pacira BioSciences, Inc.'s AOCI changed year-over-year?
- Pacira BioSciences, Inc.'s AOCI increased by 155.7% year-over-year, from $1.35M to $3.46M.
- What is the long-term trend for Pacira BioSciences, Inc.'s AOCI?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s AOCI has grown at a 68.6% compound annual growth rate (CAGR), from $318K to $4.33M.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.